Deletion Mapping of Chromosome 1 in Early Onset and Late Onset Breast Tumors – AComparative Study in Eastern India

https://doi.org/10.1078/0344-0338-00423Get rights and content

Summary

Younger women exhibit more aggressive pathologic features of breast cancer (BC) compared to their older counterparts. Young age has been shown to be an independent predictor of adverse prognosis. These findings have raised the question of whether these differences are also present at the genetic level. Twenty-five early onset (age ≤ 40 years) tumors including 4 bilateral tumors, and 26 late onset(> 40 years) breast tumors, including 2 bilateral tumors, were xamined for loss of heterozygosity (LOH) at chromosome 1 using 11 polymorphic microsatellite markers. A comparative study revealed high frequencies of LOH in chr.1p36 (61%), 1p31.3 (40%), 1p21.3 (50%) and 1q22–23.2 (56%) in a younger group, and chr. 1p36 (46%), 1p34.2 (48%), and 1q22–23.2 (52%) in an older group. These differences in LOH frequency in these two age groups were significant for chr. 1p21.3(p = 0.025) only. These data suggest that the deletion pattern in early onset breast tumors is not fully identical to late onsetbreast tumors. Similar differential deletion patterns of LOH in the 5 highly deleted regions were seen in premenopausal and postmenopausal groups. An association was seen between LOH at chr.1p34.2 and chr. 23.2 and higher grade of the tumors in older women. Among the highly deleted regions, the deletion at chr.1p36 was found to occur early in both groups because of common allelic loss in the bilateral tumors.

References (50)

  • A.J. Alberg et al.

    Epidemiology, prevention and early detection of breast cancer

    Curr Opinions Oncol

    (1999)
  • R. Anbazhagan et al.

    Microsatellite instability is uncommon in breast cancer

    Clin Can Res

    (1999)
  • J. Benitez et al.

    A region of allelic imbalance in 1q31–32 in primary breast cancer coincides with recombination hot spot

    Can Res

    (1997)
  • I. Bieche et al.

    Loss and gain of distinct regions of chromosome 1q in primary breast cancer

    Clin Cancer Res

    (1995)
  • I. Bieche et al.

    Deletion mapping of chromosomal region 1p32-pter in primary breast cancer

    Genes Chromosom Cancer

    (1999)
  • P. Bonnier et al.

    Age as prognostic factor in breast cancer: relationship to pathologic and biologic features

    Int J Cancer

    (1995)
  • M. Chung et al.

    Younger women with breast carcinoma have poorer prognosis than older women

    Cancer

    (1996)
  • J. Cui et al.

    Why are the majority of hereditary cases of early-onset breast cancer sporadic? A simulation study

    Cancer Epidemiol Biomark Prev

    (2000)
  • C. Dib et al.

    A comprehensive genetic map of the human genome based on 5,264 microsatellites

    Nature

    (1996)
  • D.F. Easton

    Familial risks of breast cancer

    Breast Cancer Res

    (2002)
  • N. Eby et al.

    Familial risk and genetic susceptibility for breast cancer

    Cancer Cause Control

    (1994)
  • MH Harmer (1978) UICC TNM classification of malignant tumors, p. 47–54. 3rd ed....
  • E.N. Imyanitov et al.

    Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas

    Int J Cancer

    (2002)
  • A. Kallioniemi et al.

    Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization

    Proc Natl Acad Sci USA

    (1994)
  • H.M. Kugoh et al.

    Suggestive evidence of functionally distinct, tumor suppressor genes on chromosome 1 and 11 for human fibrosarcoma cell line, HT1080

    Oncogene

    (1990)
  • Cited by (28)

    • Expression of PIK3IP1 in the murine uterus during early pregnancy

      2018, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      AT-rich interaction domain 1a (ARID1A) is one subunit within the SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complex [14]. It is located in chromosomal region 1p36, which is a region that is often deleted within many different forms of cancer [14,15]. A high frequency of mutation of ARID1A in cancers, specifically endometrioid cancer of the uterus and ovarian clear cell and endometrioid cancer, has revealed the potential of ARID1A to be defined as a tumor suppressor [16,17].

    • Role of the EphB2 receptor in autophagy, apoptosis and invasion in human breast cancer cells

      2014, Experimental Cell Research
      Citation Excerpt :

      For example, deletions at chr. 1p36 region, where EphB2 is localized, were very frequently found in breast cancers [11,62], but the specific role of EphB2 in these cancers is not known. In the present work we assessed EphB2 expression in different models of breast cell lines and human clinical tissues and we identified an important role for this receptor in regulating three different homeostatic processes: autophagy, apoptosis and invasion.

    • Mitochondria-mediated apoptosis in patients with adenocarcinoma of the breast: Correlation with histological grade and menopausal status

      2011, Breast
      Citation Excerpt :

      This may be because premenopausal breast tumours tend to be generally more aggressive than breast tumours that develop in women after menopause. This aspect is especially significant in countries like India where the incidence of breast tumours is more common in premenopausal women.32,57 The observations from the present study confirm that the differential expression patterns of Bcl-2 family proteins and caspases are involved in evasion of apoptosis and in the progression of breast cancer.

    View all citing articles on Scopus
    View full text